MAHONEY DAVID L 4

What Happened
David L. Mahoney, a director of Corcept Therapeutics (CORT), exercised 30,000 stock options on 2026-03-13 at a $5.86 strike price (cost = $175,800). To satisfy the exercise/tax obligation, 5,469 shares were withheld at a reported market value of $32.15/share (~$175,828). The remaining 24,531 shares were transferred without consideration to the David L. Mahoney and Winnifred C. Ellis 1998 Family Trust (recorded as a gift/transfer).

Key Details

• Transaction date: 2026-03-13 (Form 4 filed 2026-03-17; filing appears within the 2-business-day window).
• Option exercise: 30,000 shares exercised at $5.86 each (total exercise cost $175,800).
• Withholding/tax: 5,469 shares withheld at $32.15/share (~$175,828) to cover exercise/taxes (net/cashless withholding per footnote).
• Gift/transfer: 24,531 shares transferred to family trust (no consideration).
• Derivative status: options were fully exercisable (footnote).
• Shares owned after transaction: not specified in the supplied filing summary.
• Filing remarks: power of attorney on file with the SEC.

Context
This was an option exercise (insider converted options into common shares). The withholding of shares to cover the exercise and taxes is a routine, administrative step in a cashless exercise and does not represent an open-market sale. The transfer of shares to a family trust is a non-market gift/transfer and should not be interpreted as a public market sentiment signal.